German Leprosy and Tuberculosis Association, Lome, BP, 2271, Togo.
Department of Public Health, Faculty of Health Sciences, University of Lome, Lomé, Togo.
BMC Infect Dis. 2024 Jun 16;24(1):588. doi: 10.1186/s12879-024-09492-w.
Leprosy, or Hansen's disease, is a chronic infectious disease caused by Mycobacterium leprae. Togo achieved the target of eliminating leprosy as a public health problem in 2000 (less than 1 case/10 000 population). However, new cases of leprosy are still being reported. The aim of this study was to describe and map trends of leprosy cases notified in Togo from 2010 to 2022.
This was a descriptive cross-sectional study covering a thirteen-year period from January 1, 2010, to December 31, 2022. The data of the study were leprosy surveillance system's data collected monthly between 2010 and 2022. The estimated number of leprosy cases and the incidence rate of leprosy cases were reported for the whole population by region, by district, by calendar year (2010-2022) and by target sub-population (children under 15, women and people with disabilities). Observed case incidence rates were mapped by health district and by year.
From January 1, 2010, to December 31, 2022, 1031 new cases of leprosy were diagnosed in Togo. The median age of subjects was 46 years (interquartile range: 33-60), with extremes from 4 to 96 years. Half the subjects were women (50.7%). Variations in the leprosy incidence rate by year show an increase between 2010 and 2022, from 0.7 cases /100,000 population to 1.1 /100,000 population respectively. From 2010 to 2022, the proportion of cases in children remained low, between 0 and 9%. The proportion of women fluctuated between 39.7% and 67.2% between 2010 and 2017, then stabilized at an average of 50% between 2018 and 2022. The proportion of multi-bacillary leprosy cases increased quasi-linearly between 2010 and 2022, from 70 to 96.6%. Mapping of leprosy cases showed that leprosy was notified in all Togo health districts during the study period, apart from the Lacs district, which reported no leprosy cases.
Togo has achieved the elimination of leprosy as a public health problem. However, the increase in the number of new leprosy cases and the proportion of leprosy cases in children indicate that transmission of the disease is continuing and that supplementary measures are needed.
麻风病,又称汉森病,是由麻风分枝杆菌引起的慢性传染病。多哥于 2000 年实现了消除麻风病这一公共卫生问题的目标(每 10000 人口中少于 1 例)。然而,仍有新的麻风病病例报告。本研究的目的是描述和绘制多哥 2010 年至 2022 年期间报告的麻风病病例趋势。
这是一项描述性的横断面研究,涵盖了 2010 年 1 月 1 日至 2022 年 12 月 31 日的十三年时间。该研究的数据来自 2010 年至 2022 年期间每月收集的麻风病监测系统数据。按地区、区、日历年(2010-2022 年)和目标亚人群(15 岁以下儿童、妇女和残疾人)报告了整个人群的麻风病估计病例数和发病率。通过卫生区和年份绘制了观察到的病例发病率图。
2010 年 1 月 1 日至 2022 年 12 月 31 日期间,多哥诊断出 1031 例新的麻风病病例。患者的中位年龄为 46 岁(四分位间距:33-60),范围为 4-96 岁。一半的患者为女性(50.7%)。发病率年度变化显示,2010 年至 2022 年间呈上升趋势,分别从 0.7/100000 人上升至 1.1/100000 人。2010 年至 2022 年期间,儿童病例比例较低,介于 0 至 9%之间。2010 年至 2017 年期间,女性比例在 39.7%至 67.2%之间波动,然后在 2018 年至 2022 年期间稳定在平均 50%。2010 年至 2022 年间,多菌型麻风病病例比例呈准线性增长,从 70%增加到 96.6%。麻风病病例的绘图显示,在研究期间,除了没有麻风病病例报告的拉克斯区外,多哥所有的卫生区都报告了麻风病病例。
多哥已实现消除麻风病这一公共卫生问题的目标。然而,新的麻风病病例数量增加以及儿童病例比例增加表明,该疾病的传播仍在继续,需要采取补充措施。